Sage Journals: Discover world-class research

Abstract

Background

Curcumin has been reported to have many benefits, including anti-inflammatory, anti-cancer, and so on. In this research, we aimed to investigate the function of curcumin on lipopolysaccharide (LPS)-injured H9c2 cells.

Methods

H9c2 cells stimulated by LPS mimic the in vitro model of myocarditis injury. Comparative Toxicogenomics Database (CTD) was applied to detect the genes associated with curcumin. GEO database was used to analyze Intercellular Adhesion Molecule 1 (ICAM1) and CD40 expression in myocarditis patients. KEGG enrichment analysis was employed to investigate the meaningful pathways related to differentially expressed genes. Cell proliferation, apoptosis, expression of ICAM1/CD40/P65- NF-κB, and level of TNF-α, IL-6, and IL-10 were observed by cell counting kit-8, flow cytometry and western blotting assays, ELISA assay, respectively.

Results

After curcumin treatment, the decreased activity of H9c2 cells evoked by LPS was improved. ICAM1 and CD40, which highly expressed in myocarditis patients, were identified as targets of curcumin and negatively regulated by curcumin. Inhibition of ICAM1 or CD40 strengthened the protective effect of curcumin on LPS-evoked H9c2 cells damage, accompanied by increased cell viability and decreased cell apoptosis and inflammation. Additionally, addition of curcumin or depletion of ICAM1/CD40 suppressed p-P65 NF-κB expression.

Conclusions

Curcumin mitigated LPS-evoked H9c2 cells damage by suppression of ICAM1/CD40/NF-κB, providing a potential molecular mechanism for the clinical application of curcumin.

Keywords

Curcumin intercellular adhesion molecule 1 CD40 NF-κB myocarditis

Introduction

Myocarditis refers to the clinical and histological manifestations of a broad range of pathological immune processes in the heart, occurring in the myocardium of both children and adults.¹ There are various causes of myocarditis and the most common type of myocarditis is viral myocarditis, which is caused by viral infection.² Previous studies have documented the occurrence of apoptosis in myocarditis infection of the heart, which plays an important role in the pathogenesis of myocarditis.^3,4 However, if left untreated, myocarditis wound trigger arrhythmia, severe heart failure, and so on.⁵ Although some chemical drugs have certain curative effects on myocarditis, they are often accompanied by more or less side effects.⁶ However, several reports revealed that some herbal medicines can attenuate the symptoms of myocarditis, such as Astragaloside IV of Astragalus membranaceus (Fisch.) Bunge and Scutellaria baicalensis Georgi .² Therefore, it is of great significance to find effective herbs to improve myocarditis injury.

Curcumin is a polyphenol found in turmeric, which was first discovered by Vogel and Pelletier from the rhizomes of turmeric, Curcuma longa L.⁷ Recently, curcumin has attracted wide attention because of its profound medicinal values.⁸ In addition to its antioxidant and anti-inflammatory activities, curcumin has also been reported to have health benefits, such as improving brain function.⁷ Multiple in vivo studies have also reported its potential against tumors, diabetes, obesity, neurodegenerative disease, and depression.⁹ Because of curcumin’s magical properties, it has been marketed in various forms, such as tablets, capsules, ointments, energy drinks, soaps, and cosmetics in several countries.¹⁰ However, how curcumin could present these multitudinous effects has been a clandestine over the years. Analysis from Comparative Toxicogenomics Database (CTD) discovered that Intercellular Adhesion Molecule 1 (ICAM1) and CD40 might be regulated by curcumin. However, the specific mechanism of curcumin action on ICAM1 and CD40 in myocarditis has not been reported.

Lipopolysaccharide (LPS), as the main component of the cell wall of Gram-negative bacteria, is one of the important regulator of shock and inflammation. LPS, which usually cause systemic inflammation, multiple organ failure, as well as cardiac function injury, was usually utilized to stimulate cardiomyocyte toxicity. For instance, LPS can lead to damage in rats and H9c2 cells.¹¹

Herein, we investigated the molecular mechanism of curcumin suppressing apoptosis evoked by LPS treatment in H9c2 cells, as well as the impact of curcumin on crucial pathway. These findings will afford a novel molecular biology base for the clinical application of curcumin in handling with myocarditis and promote the progression and application of curcumin.

Materials and methods

Data collection

CTD was used to explore the key genes related to curcumin. Gene Expression Omnibus (GEO) database (GSE19496) covering 12 cases of myocarditis samples and 12 cases of normal samples were used to analyze ICAM1 and CD40 expression. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis was employed to investigate the meaningful pathways related to differentially expressed genes in myocarditis samples.

Cell culture and treatment

Rat myocardial cells H9c2 were bought from American Type Culture Collection (ATCC), and grown in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS) and antibiotic in an incubator at 37°C of 5% CO₂. In vitro model of myocarditis were constructed using H9c2 cells stimulated continuously by LPS for 12 h. SiICAM1 (5^′-CGGCTGACGTGTGCAGTAATA-3^′) and siCD40 (5^′-GCAGGCACAAACAAGACTGATCTC-3^′) were applied to knockdown ICAM1 and CD40 expression, respectively. Si-con (5^′-CGAGAACTCACTGGTCTGACAC-3^′) was served as a standard control. These small fragments were transfected into cells by Lipofectamine 2000 following the manufacture’s direction.

Cell viability assay

Cell viability of H9c2 cells was detected by cell counting kit-8 to evaluate the growth ability of H9c2 cells. Briefly, H9c2 cells were seeded in a 96-well plate with 1000 cells/well. After different stimulation, the CCK-8 reagent was put into the culture medium and cultivated for 1.5 h at 37°C. The optical density was read at 450 nm with a microplate reader. The experiment was repeated three times.

Apoptosis assay

The apoptosis rates of H9c2 cells undergoing different treatments were determined by using Annexin V-FITC and propidium iodide (PI) apoptosis detection kit by flow cytometry. After various stimulations, cells were rinsed with PBS and incubated with 10 μL Annexin V-FITC and 5 μL PI for 15 min away from the light at room temperature. Flow cytomery analysis was performed by a FACScan flow cytometry, and the data were processed by FlowJo software. The experiment was repeated three times.

qRT-PCR

TRIzol reagent was used to isolate the whole RNA from H9c2 cells following the supplier’s direction. Reverse transcription was carried out by using PrimeScript^TM RT reagent kit. For analysis of ICAM1 and CD40, a SYBR Green PCR kit was applied. GAPDH was amplified as a standard control. The relative expression levels of ICAM1 and CD40 were assessed by using 2^−ΔΔCT method. The experiment was repeated three times.

Western blot assay

Total protein was isolated from H9c2 cells with the support of RIPA lysis buffer and quantified with the assistance of the bicinchoninic acid protein assay kit. Nuclear extracts from H9c2 cells were also prepared using a nuclear protein extraction kit (Beyotime Biotechnology, China). Thereafter, equal amount (20 μg) of protein was separated by SDS-PAGE and then blotted onto the PVDF membranes. The membranes were incubated with the primary antibodies against ICAM1 (1:1000, 4915, CST), CD40 (1:1000, 86,165, CST), p-P65 NF-κB (1:1000, 3033, CST), P65 NF-κB (1:1000, 8242, CST), p-IkBα (1:1000, 2859, CST), N-cadherin (1:1000, 13,116, CST), and GAPDH (1:1000, 5174, CST) at 4°C for 24 h. Then, the membranes were washed by PBS and incubated with secondary antibody for 2 h at ambient temperature. Finally, the bands were visualized by using ECL detection kit and quantified by using Image J software. The experiment was repeated three times.

Enzyme-linked immuno sorbent assay (ELISA)

The level of TNF-α, IL-6 and IL-10 in cellular supernatant were measured by ELISA kits according to the manufacturer’s instructions (R&D, Minneapolis, MN, USA). All measurements were performed in triplicate. TNF-α (catalog: RTA00), IL-6 (catalog: R6000 B) and IL-10 (catalog: R1000) ELISA kit was purchased from R&D (Minneapolis, MN, USA).

Statistical analysis

Statistics were analyzed by using GraphPad Prism 8.0 (GraphPad Software, USA). Data used in this study were exhibited as mean ± standard deviation (SD) and statistically analyzed by ANOVA followed by Bonferroni’s post hoc test. Data were deemed as significant when p less than 0.05.

Results

The decreased viability and increased apoptosis of H9c2 cells triggered by LPS were suppressed by curcumin

To detect the impacts of curcumin on LPS-evoked cell damage, optimum dose of curcumin on H9c2 cells that has no remarkable inhibitory effect on cell proliferation was first elected. As exhibited in Figure 1(a), 0–20 µM curcumin had no evident effect on cell proliferation, but 50 μM curcumin notably reduced cell viability. Moreover, the data in Figure 1(b) revealed that curcumin attenuated LPS-evoked cell proliferation suppression in a dose-dependent mode. We observed that 20 or 50 μM curcumin significantly improved LPS-induced cell viability decline. Therefore, 20 μM curcumin was picked up in the next experiments. Subsequently, the data presented in Figure 1(c) and (d) exhibited that decreased cell viability and elevated cell apoptosis rate induced by LPS stimulation were inhibited by curcumin treatment. These results indicated that curcumin availably improved LPS-evoked cell damage.

Figure 1.

Curcumin reduced lipopolysaccharide (LPS)-induced H9c2 cells damage (a). Analysis from CCK-8 showed that the viability of H9c2 cells changed under the stimulation of different concentration of curcumin (b). The viability of H9c2 cells with LPS and curcumin treatment was detected by CCK-8 (c). The decrease in H9c2 cells viability induced by LPS was alleviated by curcumin (d). Curcumin attenuated the apoptosis of H9c2 cells induced by LPS. ^*p < 0.05 and ^**p < 0.01 vs. Control, ^#p < 0.05 and ^##p < 0.01 vs. LPS.

The potential targets of curcumin were explored

Analysis from CTD showed that ICAM1 and CD40 were identified as targets of curcumin (supplementary figure). Importantly, KEGG enrichment analysis showed that ICAM1 and CD40 were closely related to NF-κB pathway (Figure 2(a)). Moreover, data from GEO database showed that ICAM1 (Figure 2(b)) and CD40 (Figure 2(c)) were both highly expressed in myocarditis patients (n = 12) compared with the normal samples (n = 12). Thereafter, we observed that LPS stimulation increased ICAM1, CD40, p-P65 NF-κB, p-IkBα and N-cadherin expression. However, the elevated expression of ICAM1, CD40, p-P65 NF-κB, p-IkBα, and N-cadherin by LPS treatment were inhibited by curcumin stimulation (Figure 2(d)–(k)). These data illustrated that ICAM1, CD40, and p-P65 NF-κB expression in LPS model could be affected by curcumin.

Figure 2.

Intercellular adhesion molecule 1 (ICAM1) and CD40 were identified as targets of Curcumin (a). KEGG enrichment analysis was used to detect the pathways related to differentially expressed genes in myocarditis (b). ICAM1 expression was obviously increased in myocarditis patients (n = 12) compared with the control (n = 12) (c). A marked augmentation of CD40 was happened in myocarditis patients (n = 12) than the control (n = 12) (d–k). Western blotting assay exhibited that the increased expression of ICAM1, CD40 and p-P65 NF-Κb, p-IkBα and N-cadherin induced by lipopolysaccharide were suppressed by curcumin treatment. ^**p < 0.01 and ^***p < 0.001 vs. Control, ^##p < 0.01 and ^###p < 0.001 vs. LPS.

Curcumin alleviated the LPS-induced H9c2 damage by reducing ICAM1/CD40/NF-κB

To further study the effect of ICAM1 and CD40 on the protective action of curcumin in LPS-evoked H9c2 cells, siICAM1 and siCD40 were used. As presented in Figure 3(a), the expression of ICAM1 was decreased after H9c2 cells transfected with siICAM1. As shown in Figure 3(b), the pro-proliferative effect of curcumin on H9c2 cells was obviously enhanced by inhibiting ICAM1. Moreover, the suppressing impact of curcumin on LPS-evoked cell apoptosis was notably strengthened by depletion of ICAM1 (Figure 3(c)). As expected, the blocking effect of curcumin on p-P65 NF-κB, p-IkBα and N-cadherin expression was enhanced by depletion of ICAM1 (Figure 3(e)–(k)). Similarly, the expression of CD40 was decreased after H9c2 cells transfected with siCD40 (Figure 4(a)). In addition, we observed that knockdown of CD40 enhanced the promoting effect of curcumin on the proliferation of H9c2 (Figure 4(b)). Besides, knockdown of CD40 significantly strengthened the inhibitory effect of curcumin on LPS-evoked H9c2 cells apoptosis (Figure 4(c)). Additionally, knockdown of CD40 strengthened the inhibitory effect of curcumin on the expression of p-P65 NF-κB, p-IkBα, and N-cadherin (Figure 4(e)–(k)). These results suggested that curcumin alleviated LPS-evoked H9c2 cells damage by targeting ICAM1/CD40/NF-κB pathway.

Figure 3.

Curcumin alleviated H9c2 cells damage by regulation of Intercellular Adhesion Molecule 1 (ICAM1)/NF-κB (a). The expression of ICAM1 was detected after H9c2 cells transfected with siICAM1 by qRT-PCR (b). CCK-8 assay revealed that depletion of ICAM1 enhanced the promoting effect of curcumin on H9c2 cells viability (c-d). Flow cytometry assay suggested that knockdown of ICAM1 strengthened the inhibitory effect of curcumin on lipopolysaccharide-triggered H9c2 cells apoptosis (e–k). Western blotting assay indicated that ICAM1, p-P65 NF-κB, p-IkBα and N-cadherin expression was suppressed by curcumin, depletion of ICAM1 increased the inhibitory effect of curcumin on p-P65 NF-κB expression. $\hat{p}$ < 0.001 vs. control, ^*p < 0.05 and ^**p < 0.01 and ^***p < 0.001 vs. LPS, ^##p < 0.01 and ^###p < 0.001 vs. LPS+Curcumin, ^@@p < 0.01 and ^@@@p < 0.001 vs. LPS+si-ICAM1.

Figure 4.

Curcumin attenuated LPS-evoked H9c2 cells damage via targeting CD40/NF-κB (a). The expression of CD40 was detected after H9c2 cells transfected with siCD40 by qRT-PCR (b). Analysis from CCK-8 assay indicated that depletion of CD40 increased the promoting effect of curcumin on H9c2 cells viability (c-d). Data from flow cytometry exhibited that depletion of CD40 enhanced the inhibitory effect of curcumin on lipopolysaccharide-triggered H9c2 cells apoptosis (e–k). Western blotting assay indicated that CD40, p-P65 NF-κB, p-IkBα and N-cadherin expression was suppressed by curcumin, depletion of CD40 increased the inhibitory effect of curcumin on p-P65 NF-κB expression. $\hat{p}$ < 0.001 vs. control, ^*p < 0.05 and ^**p < 0.01 vs. LPS, ^#p < 0.05 and ^##p < 0.01 and ^###p < 0.001 vs. LPS+Curcumin, ^@p < 0.05 and ^@@p < 0.01 and ^@@@p < 0.001 vs. LPS+si-CD40.

Curcumin attenuated the inflammation of LPS-induced H9c2 cells via targeting ICAM1/CD40.

To explore the effect of curcumin on the inflammation of LPS-induced H9c2 cells, we examined the levels of inflammatory factors in LPS-induced H9c2 cells. The result showed that curcumin inhibited the TNF-α and IL-6 levels, while promoted the level of IL-10 in LPS-induced H9c2 cells; moreover, siICAM1 and siCD40 further promoted the effect of curcumin on the level inflammatory factors of LPS-induced H9c2 cells (Figure 5(a)–(f)).

Figure 5.

Curcumin attenuated the inflammation of LPS-induced H9c2 cells via targeting Intercellular Adhesion Molecule 1 (ICAM1)/CD40 (a–c). The levels of TNF-α, IL-6 and IL-10 were detected after H9c2 cells transfected with siICAM1 by enzyme-linked immuno sorbent assay (ELISA) (d–f). The levels of TNF-α, IL-6 and IL-10 were detected after H9c2 cells transfected with siCD40 by ELISA. ^**p < 0.01 and ^***p < 0.001 vs. LPS, ^#p < 0.05 and ^##p < 0.01 vs. LPS+Curcumin, ^@p < 0.05 and ^@@p < 0.01 vs. LPS+si-ICAM1, $\hat{p}$ < 0.05 and $\hat{p}$ < 0.01 vs. LPS+si-CD40.

Discussion

In this study, we discovered that curcumin alleviated the LPS-triggered damage in H9c2 cells. ICAM1 and CD40, which were regulated by curcumin, were highly expressed in myocarditis patients and LPS-induced H9c2 cells. By KEGG enrichment analysis, we discovered that ICAM1 and CD40 were closely related to NF-κB pathway. Under the treatment of curcumin, upregulation of ICAM1 and CD40 in LPS-induced H9c2 cells was suppressed. Moreover, the activated NF-κB pathway in the LPS-induced H9c2 cells was inhibited with curcumin treatment. Collectively, our data illustrated that curcumin mitigated LSP-evoked H9c2 cells damage by targeting ICAM1/CD40/NF-κB.

Currently, the therapeutic effects of herbal medicine on viral myocarditis have been more and more identified by researchers.¹² For example, Baicalin mitigated the symptoms of myocarditis by inhibiting NF-κB and PDCD4/JNK pathways.² Astragaloside IV protected myocarditis against injury by suppressing NF-κB pathway.¹³ Previously, curcumin has been discovered to protect mice from coxsackievirus B3-induced myocarditis by blocking the PI3K/Akt/NF-κB pathway.¹⁴ However, the detailed relationship between curcumin and NF-κB pathway remains unknown. In our study, we not only observed that curcumin can alleviate H9c2 cells damage, but also found that curcumin worked by targeting ICAM1/CD40 to inactivate the NF-κB pathway. It has been reported that curcumin inhibits cigarette smoke-induced inflammation via modulating the PPARγ-NF-κB signaling pathway¹⁵; Curcumin reduces inflammation in knee osteoarthritis rats through blocking TLR4/MyD88/NF-κB signal pathway.¹⁶ Similar to these studies, we found that curcumin inhibits inflammation of LPS-induced H9c2 cells by targeting ICAM1/CD40 to regulate NF-κB pathway

ICAM1 is a cell surface glycoprotein and an adhesion receptor expressed in immune cells and endothelial cells, which regulated leukocyte recruitment from circulation to sites of inflammation.^17,18 ICAM1 concentrations have been found to be elevated in patients with cardiovascular disease and inflammation.¹⁹ In our study, ICAM1 was also found to be highly expressed in patients with myocarditis. Additionally, ICAM1 was verified as a target of curcumin. Soveyd and colleagues reported that curcumin regulated the gene expression and serum levels of ICAM1 by influencing transcription factors, thereby improving the symptoms of migraine patients.²⁰ Significantly, we observed that depletion of ICAM1 enhanced the mitigative effect of curcumin on H9c2 cells damage, which confirmed the relationship between curcumin and ICAM1.

CD40 is a co-stimulatory molecule belonging to the tumor necrosis factor super-family.²¹ CD40 is a marker of pro-inflammatory cytokines and plays an important role in the occurrence and maintenance of inflammatory responses.²² CD40, which has been found to be widely overexpressed in myocarditis, plays an important role in the pathogenesis of myocarditis and may become a potential target for the treatment of myocarditis.^23,24 Similarly, we discovered that CD40 was highly expressed in myocarditis patients, and silencing CD40 could inhibit the pro-inflammatory factors (TNF-α and IL-6) level and promoted the anti-inflammatory factor (IL-10) level. Importantly, CD40 was identified as a target of curcumin. A previous study revealed that curcumin alleviated angiotensin-induced endothelial cells injury by suppressing CD40 expression.²⁵ Herein, we observed that curcumin mitigated H9c2 cells damage by reducing CD40 expression, revealing the association between curcumin and CD40.

NF-κB pathway is implicated in the pathogenesis of myocarditis by regulating immune response, and the exaggerated inflammatory response induced by NF-κB pathway in myocarditis is the primary cause chronic heart failure and cardiac hypertrophy.²⁶ Previous reports have indicated that drug that targets NF-κB pathway can be used to treat myocarditis.²⁷ Curcumin, as a NF-κB suppressor, has been illustrated to exert protective function in several diseases by inactivating NF-κB pathway, such as osteoarthritis, airway inflammation and cancers, and of course myocarditis.^14,28–30 In this study, expression level of p-P65 NF-κB increased in LPS-induced H9c2 cells. However, with curcumin treatment, p-P65 NF-κB expression significantly reduced. Additionally, we also observed that ICAM1 and CD40 were closely related to NF-κB pathway. Moreover, knockdown of ICAM1 or CD40, p-P65 NF-κB expression decreased significantly again. All these data indicated that curcumin alleviated H9c2 cells damage by inactivating NF-κB pathway through targeting ICAM1 and CD40.

Taken together, suppression of ICAM1 and CD40 enhanced curcumin’s alleviating effect on H9c2 cells damage triggered by LPS. A reduction of p-P65 NF-κB expression was observed in the LPS-induced H9c2 cells after inhibiting ICAM1/CD40 or adding curcumin, indicating that curcumin alleviated H9c2 cells damage by blocking ICAM1/CD40/NF-κB signaling.

Footnotes

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

ORCID iD

Yan Zhao

References

Ren

Zhao

Ren

, et al. Astragalus polysaccharide alleviates LPS-induced inflammation injury by regulating miR-127 in H9c2 cardiomyoblasts. Int Journal Immunopathology Pharmacology 2018; 32: 2058738418759180. DOI: 10.1177/2058738418759180.

Liu

Wang

Zhao

. Baicalin relieves lipopolysaccharide-evoked inflammatory injury through regulation of miR-21 in H9c2 cells. Phytotherapy Res 2020; 34: 1134–1141. DOI: 10.1002/ptr.6583.

Corsten

Schroen

Heymans

. Inflammation in viral myocarditis: friend or foe? Trends Molecular Medicine 2012; 18: 426–437. DOI: 10.1016/j.molmed.2012.05.005.

Zhang

Sun

, et al. Overexpression of microRNA-133b reduces myocardial injuries in children with viral myocarditis by targeting Rab27B gene. Cellular Molecular Biol 2017; 63: 80–86. DOI: 10.14715/cmb/2017.63.10.13.

Escher

Tschöepe

Lassner

, et al. Myocarditis and inflammatory cardiomyopathy: from diagnosis to treatment. Turk Kardiyoloji Dernegi Arsivi-Archives the Turkish Society Cardiol 2015; 43: 739–748. DOI: 10.5543/tkda.2015.47750.

Chen

Wang

, et al. Corticosteroids for viral myocarditis. The Cochrane Database Systematic Reviews 2013; 2013: CD004471. DOI: 10.1002/14651858.CD004471.pub3.

Kunnumakkara

Bordoloi

Padmavathi

, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. British Journal Pharmacology 2017; 174: 1325–1348. DOI: 10.1111/bph.13621.

Tsuda

. Curcumin as a functional food-derived factor: degradation products, metabolites, bioactivity, and future perspectives. Food & Function 2018; 9: 705–714. DOI: 10.1039/c7fo01242j.

Gupta

Sung

Kim

, et al. Multitargeting by turmeric, the golden spice: from kitchen to clinic. Molecular Nutrition & Food Res 2013; 57: 1510–1528. DOI: 10.1002/mnfr.201100741.

10.

Prasad

Tyagi

Aggarwal

. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treatment 2014; 46: 2–18. DOI: 10.4143/crt.2014.46.1.2.

11.

Chen

Liu

Feng

, et al. Salidroside suppressing LPS-induced myocardial injury by inhibiting ROS-mediated PI3K/Akt/mTOR pathway in vitro and in vivo. Journal Cellular Molecular Medicine 2017; 21: 3178–3189. DOI: 10.1111/jcmm.12871.

12.

Liu

, et al. Herbal medicines for viral myocarditis. The Cochrane Database Systematic Reviews 2013; 28: CD003711. DOI: 10.1002/14651858.CD003711.pub5.

13.

Gui

Chen

, et al. Remission of CVB 3‐induced myocarditis with astragaloside IV treatment requires A20 (TNFAIP 3) up‐regulation. Journal Cellular Molecular Medicine 2015; 19: 850–864. DOI: 10.1111/jcmm.12459.

14.

Song

Cai

, et al. Curcumin protects mice from coxsackievirus B3-induced myocarditis by inhibiting the phosphatidylinositol 3 kinase/Akt/Nuclear factor-κB pathway. Journal Cardiovascular Pharmacology Therapeutics 2013; 18: 560–569. DOI: 10.1177/1074248413503044.

15.

Sun

Mohammadtursun

, et al. Curcumin inhibits cigarette smoke-induced inflammation via modulating the PPARγ-NF-κB signaling pathway. Food & Function 2019; 10: 7983–7994. DOI: 10.1039/c9fo02159k.

16.

Zhang

Zeng

. Curcumin reduces inflammation in knee osteoarthritis rats through blocking TLR4/MyD88/NF‐κB signal pathway. Drug Development Research 2019; 80: 353–359. DOI: 10.1002/ddr.21509.

17.

Liu

Lee

Chen

, et al. PM2.5-induced oxidative stress increases intercellular adhesion molecule-1 expression in lung epithelial cells through the IL-6/AKT/STAT3/NF-κB-dependent pathway. Particle Fibre Toxicology 2018; 15: 4. DOI: 10.1186/s12989-018-0240-x.

18.

Zhang

Yan

, et al. Proinflammatory cytokines correlate with early exercise attenuating anxiety-like behavior after cerebral ischemia. Brain Behavior 2017; 7: e00854. DOI: 10.1002/brb3.854.

19.

Núñez

Comas

Lanuza

, et al. A functional analysis on the interspecies interaction between mouse LFA-1 and human intercellular adhesion molecule-1 at the cell level. Frontiers Immunology 2017; 8: 1817. DOI: 10.3389/fimmu.2017.01817.

20.

Soveyd

Abdolahi

Djalali

, et al. The combined effects of ω -3 fatty acids and nano-curcumin supplementation on intercellular adhesion molecule-1 (ICAM-1) gene expression and serum levels in migraine patients. CNS & Neurological Disorders - Drug Targets 2018; 16: 1120–1126. DOI: 10.2174/1871527317666171213154749.

21.

Narváez

Guiteras

Sola

, et al. siRNA-silencing of CD40 attenuates unilateral ureteral obstruction-induced kidney injury in mice. PloS One 2019; 14: e0215232. DOI: 10.1371/journal.pone.0215232.

22.

Elgueta

Benson

de Vries

, et al. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunological Reviews 2009; 229: 152–172. DOI: 10.1111/j.1600-065X.2009.00782.x.

23.

Gong

Han

Zou

, et al. Attenuation of experimental autoimmune myocarditis by si-RNA mediated CD40 silencing. Int heart Journal 2014; 55: 539–545. DOI: 10.1536/ihj.14-125.

24.

, et al. MiR‐16, as a potential NF‐κB‐related miRNA, exerts anti‐inflammatory effects on LPS‐induced myocarditis via mediating CD40 expression: a preliminary study. Journal Biochemical Molecular Toxicology 2020; 34: e22426. DOI: 10.1002/jbt.22426.

25.

Xiang

, et al. MiR-590-3p mediates the protective effect of curcumin on injured endothelial cells induced by angiotensin II. American Journal Translational Research 2017; 9: 289–300.

26.

Maier

Schips

Wietelmann

, et al. Cardiomyocyte-specific I B kinase (IKK)/NF- B activation induces reversible inflammatory cardiomyopathy and heart failure. Proceedings the National Academy Sciences 2012; 109: 11794–11799. DOI: 10.1073/pnas.1116584109.

27.

Valaperti

. Drugs targeting the canonical NF-κB pathway to treat viral and autoimmune myocarditis. Current Pharmaceutical Design 2016; 22: 440–449. DOI: 10.2174/1381612822666151222160409.

28.

Chin

. The spice for joint inflammation: anti-inflammatory role of curcumin in treating osteoarthritis. Drug Design, Development Therapy 2016; 10: 3029–3042. DOI: 10.2147/dddt.s117432.

29.

Yuan

Liu

, et al. Curcumin attenuates airway inflammation and airway remolding by inhibiting NF-κB signaling and COX-2 in cigarette smoke-induced COPD mice. Inflammation 2018; 41: 1804–1814. DOI: 10.1007/s10753-018-0823-6.

30.

Kunnumakkara

Bordoloi

Harsha

, et al. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. Clinical Science 2017; 131: 1781–1799. DOI: 10.1042/cs20160935.

Curcumin alleviated lipopolysaccharide-evoked H9c2 cells damage via suppression of intercellular adhesion molecule 1/CD40/NF-κB signaling

Abstract

Background

Methods

Results

Conclusions

Keywords

Introduction

Materials and methods

Data collection

Cell culture and treatment

Cell viability assay

Apoptosis assay

qRT-PCR

Western blot assay

Enzyme-linked immuno sorbent assay (ELISA)

Statistical analysis

Results

The decreased viability and increased apoptosis of H9c2 cells triggered by LPS were suppressed by curcumin

The potential targets of curcumin were explored

Curcumin alleviated the LPS-induced H9c2 damage by reducing ICAM1/CD40/NF-κB

Curcumin attenuated the inflammation of LPS-induced H9c2 cells via targeting ICAM1/CD40.

Discussion

Footnotes

Declaration of conflicting interests

Funding

ORCID iD

References